Targeted Venetoclax Therapy in t(11;14) Multiple Myeloma: Real World Data From Seven Hungarian Centers

Overview of attention for article published in Pathology & Oncology Research, February 2022

Altmetric Badge

About this Attention Score

Average Attention Score compared to outputs of the same age
Average Attention Score compared to outputs of the same age and source

Mentioned by

twitter: 3 X users

Citations

dimensions_citation: 10 Dimensions

Readers on

mendeley: 31 Mendeley

Summary X Dimensions citations

So far, Dimensions has found 10 publications that cite this research output.

10

The most recent citing publications are shown below. View all 10 publications that cite this research output on Dimensions.

Venetoclax in the treatment of secondary plasma cell leukemia with translocation t(11;14): a case report and literature review

Article in Frontiers in Oncology (July 2024)

Advancing the understanding of venetoclax in t(11;14)-positive multiple myeloma: a comprehensive review of clinical evidence and future prospects

Article in Hematology (December 2023)

Use of venetoclax in t(11;14) positive relapsed/refractory multiple myeloma: A systematic review

Article in Journal of Oncology Pharmacy Practice (December 2023)

This page shows the most recent citations of this research output.

Click here to find out how to access more activity.